SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NEXL

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: arnold silver who wrote (1387)7/6/1998 1:46:00 PM
From: John Grabiec  Read Replies (1) of 1704
 
Has anyone heard anything about the following (which I got off DEJANEWS)? I have not heard of this YEDA link concerning
Vimrxyn.

The following is not mine........

the story is that YEDA has discovered a way to grow spinal tissue (prevent
paralysis) in mice by injecting immune system macrophages into the spinal
fluid. VMRX is associated with Yeda (see below); and, will most likely go from
1 dollar a share to 6 dollars a share or MORE in my opinion based on the
highest (4/share) that it has gone; but, always ask your stock broker before
buying any stock on your own. I have personally invested a large portion of
my money in VMRX also when I heard the recent news (I personally think it will
go up 40 times its price in the next 2 years)....especially that VMRX is at its
lowest in the stock curve right now!
Buy low; sell high they say; so, I think you made a smart choice.

here is an excerpt from the web:

VIMRx Pharmaceuticals Inc. (VMRX) is engaged in developing therapeutic and
related products ....................................
VIMRxyn as a treatment for viral and retroviral diseases, including AIDS, and
as a means of inactivating HIV and other retroviruses in blood collected for
transfusions under a worldwide exclusive license to commercialize and exploit
synthetic hypericin compounds for enumerated purposes acquired from New York
University and YEDA Research and Development Co., Ltd., an Israeli corporation
engaged in the commercial exploitation of scientific developments by scientists
at a Weizmann Institute of Science in Israel, (New York University and YEDA,
collectively, the "Hypericin Licensors").
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext